# Amphenol Corp: Form 10-Q for the period ended Mar 31, 2015

- Company: [Amphenol Corp](/companies/aph.md) (CIK 820313)
- Form: 10-Q
- Filed: 2015-05-08
- Accepted by EDGAR: May 8, 2015, 13:21 ET
- Period: 2015-03-31
- Accession: 0001104659-15-036125
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/820313/000110465915036125/a15-7228_110q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/820313/000110465915036125/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2015-03-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2015-01-01 to 2015-03-31 | $1.33bn | us-gaap:SalesRevenueGoodsNet |
| Cost of revenue | 3 months, 2015-01-01 to 2015-03-31 | $902.5m | us-gaap:CostOfGoodsSold |
| Gross profit | 3 months, 2015-01-01 to 2015-03-31 | $424.6m | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months, 2015-01-01 to 2015-03-31 | $164.4m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2015-01-01 to 2015-03-31 | $260.2m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2015-01-01 to 2015-03-31 | $17.0m | us-gaap:InterestExpense |
| Income tax | 3 months, 2015-01-01 to 2015-03-31 | $65.5m | us-gaap:IncomeTaxExpenseBenefit |
| Diluted EPS | 3 months, 2015-01-01 to 2015-03-31 | $0.57 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2015-01-01 to 2015-03-31 | $0.58 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2015-01-01 to 2015-03-31 | 317,985,645 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months, 2015-01-01 to 2015-03-31 | $188.3m | us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations |
| Capital expenditure | 3 months, 2015-01-01 to 2015-03-31 | $40.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 3 months, 2015-01-01 to 2015-03-31 | $77.5m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 3 months, 2015-01-01 to 2015-03-31 | $62.2m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2015-03-31 | $969.9m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2015-03-31 | $3.53bn | us-gaap:AssetsCurrent |
| Total assets | at 2015-03-31 | $7.03bn | us-gaap:Assets |
| Current liabilities | at 2015-03-31 | $925.7m | us-gaap:LiabilitiesCurrent |
| Long-term debt | at 2015-03-31 | $2.76bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2015-03-31 | $1.6m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | at 2015-03-31 | $2.95bn | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 1,638 characters.

### Repurchase of Equity Securities

In January 2015, the Board of Directors authorized a stock repurchase program under which the Company may repurchase up to 10 million shares of common stock during the two year period ending January 20, 2017 (the “2015 Stock Repurchase Program”). The price and timing of any such purchases under the 2015 Stock Repurchase Program will depend on factors such as levels of cash generation from operations, the volume of stock option exercises by employees, cash requirements for acquisitions, economic and market conditions and stock price. During the three months ended March 31, 2015, the Company repurchased 1.1 million shares of its common stock for approximately $62.2 million. These treasury shares have been retired by the Company and common stock and retained earnings were reduced accordingly. Through April 30, 2015, the Company has repurchased an additional 0.6 million shares of its common stock for $34.8 million. At April 30, 2015, approximately 8.3 million additional shares of common stock may be repurchased under the 2015 Stock Repurchase Program.

| Period | Total Number of Shares Purchased | Average Price Paid per Share | Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs | Maximum Number of Shares that May Yet Be Purchased Under the Plans or Programs |
| --- | ---: | ---: | ---: | ---: |
| January 1 to January 31, 2015 | 45,972 | $53.96 | 45,972 | 9,954,028 |
| February 1 to February 28, 2015 | 1,038,827 | 57.49 | 1,038,827 | 8,915,201 |
| March 1 to March 31, 2015 | — | — | — | 8,915,201 |
| Total | 1,084,799 | $57.34 | 1,084,799 | 8,915,201 |

## Market risk

As filed, 1,175 characters.

The Company, in the normal course of doing business, is exposed to the risks associated with foreign currency exchange rates and changes in interest rates. There has been no material change in the Company’s assessment of its sensitivity to foreign currency exchange rate risk since its presentation set forth in Part II, Item 7A “Quantitative and Qualitative Disclosures About Market Risk” in its 2014 Annual Report. Throughout the year, the Company may borrow under its Revolving Credit Facility, Credit Agreement and Commercial Paper Program, each of which bears interest at or trades at rates that fluctuate with LIBOR. Therefore, when the Company borrows under these debt instruments, the Company is exposed to market risk related to changes in interest rates. As of March 31, 2015, there were no LIBOR-based borrowings outstanding under the Revolving Credit Facility or Credit Agreement and borrowings under the Commercial Paper Program were at an average rate of 0.63%. The Company does not expect changes in interest rates to have a material effect on income or cash flows in 2015, although there can be no assurances that interest rates will not change significantly.

## Controls and procedures

As filed, 1,296 characters.

Under the supervision and with the participation of the Company’s management, including the Company’s Chief Executive Officer and Chief Financial Officer, the Company has evaluated the effectiveness of the design and operation of its disclosure controls and procedures as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934 (the “Exchange Act”) as of the period covered by this report. Based on their evaluation, the Chief Executive Officer and Chief Financial Officer have concluded that these disclosure controls and procedures are effective in providing reasonable assurance that information required to be disclosed by the Company in reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in Securities and Exchange Commission rules and forms and such information is accumulated and communicated to management, including the Company’s principal executive and financial officers, to allow timely decisions regarding required disclosure. There has been no change in the Company’s internal controls over financial reporting during its most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, its internal control over financial reporting.

## Risk factors

As filed, 134 characters.

There have been no material changes to the Company’s risk factors as disclosed in Part I, Item 1A of the Company’s 2014 Annual Report.

Filed May 8, 2015.
Source: SEC EDGAR, the filing index for accession 0001104659-15-036125. Last ingested by Listed: Nov 3, 2026, 18:42 ET. No prices; not investment advice.
